Deutsche Bank’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Deutsche Bank’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,624,447	Closed	-$68.5M	–	3885
2023 Q2	$68.5M	Buy	1,624,447 +1,545,140	+1,948%	+$62.5M	0.04%	433
2023 Q1	$2.82M	Buy	79,307 +28,105	+55%	+$1.02M	﹤0.01%	1497
2022 Q4	$1.88M	Buy	51,202 +44,398	+653%	+$1.75M	﹤0.01%	1697
2022 Q3	$321K	Sell	6,804 -13,020	-66%	-$841K	﹤0.01%	2651
2022 Q2	$1.42M	Buy	19,824 +7,611	+62%	+$556K	﹤0.01%	1960
2022 Q1	$989K	Buy	12,213 +59	+0.5%	+$4.99K	﹤0.01%	2353
2021 Q4	$1.25M	Sell	12,154 -5,740	-32%	-$551K	﹤0.01%	2303
2021 Q3	$1.57M	Sell	17,894 -7,443	-29%	-$674K	﹤0.01%	2302
2021 Q2	$2.27M	Sell	25,337 -596,975	-96%	-$50.4M	﹤0.01%	2106
2021 Q1	$47.2M	Buy	622,312 +605,321	+3,563%	+$45.6M	0.03%	608
2020 Q4	$1.16M	Buy	16,991 +581	+4%	+$36.2K	﹤0.01%	2344
2020 Q3	$872K	Sell	16,410 -4,423	-21%	-$263K	﹤0.01%	2293
2020 Q2	$1.21M	Sell	20,833 -27,951	-57%	-$1.5M	﹤0.01%	2088
2020 Q1	$1.92M	Sell	48,784 -11,637	-19%	-$680K	﹤0.01%	1735
2019 Q4	$3.59M	Sell	60,421 -61,466	-50%	-$3.3M	﹤0.01%	1636
2019 Q3	$6.48M	Buy	121,887 +84,396	+225%	+$4.33M	﹤0.01%	1251
2019 Q2	$1.91M	Sell	37,491 -2,043	-5%	-$95.1K	﹤0.01%	2417
2019 Q1	$2.04M	Sell	39,534 -65,816	-62%	-$3.19M	﹤0.01%	2492
2018 Q4	$4.14M	Sell	105,350 -90,917	-46%	-$4.22M	﹤0.01%	1901
2018 Q3	$10.1M	Sell	196,267 -20,345	-9%	-$996K	0.01%	1624
2018 Q2	$10.2M	Buy	216,612 +115,335	+114%	+$4.77M	0.01%	1736
2018 Q1	$3.59M	Sell	101,277 -68,202	-40%	-$2.67M	﹤0.01%	2474
2017 Q4	$7.39M	Sell	169,479 -353,792	-68%	-$16.5M	﹤0.01%	1718
2017 Q3	$27.4M	Sell	523,271 -211,004	-29%	-$11.8M	0.02%	838
2017 Q2	$43M	Buy	734,275 +314,532	+75%	+$16.3M	0.03%	576
2017 Q1	$19.2M	Sell	419,743 -138,034	-25%	-$6.87M	0.01%	898
2016 Q4	$29.3M	Sell	557,777 -60,344	-10%	-$2.92M	0.02%	686
2016 Q3	$27.6M	Buy	618,121 +280,313	+83%	+$12.2M	0.02%	760
2016 Q2	$12.9M	Sell	337,808 -69,797	-17%	-$3.07M	0.01%	1156
2016 Q1	$16.8M	Buy	407,605 +302,873	+289%	+$12.5M	0.01%	988
2015 Q4	$5.08M	Buy	104,732 +46,749	+81%	+$2.08M	﹤0.01%	1778
2015 Q3	$2.32M	Buy	57,983 +11,837	+26%	+$517K	﹤0.01%	2391
2015 Q2	$1.85M	Buy	46,146 +43,570	+1,691%	+$1.5M	﹤0.01%	2513
2015 Q1	$83K	Sell	2,576 -14,576	-85%	-$403K	﹤0.01%	4203
2014 Q4	$438K	Buy	+17,152	New	+$408K	﹤0.01%	3767

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deutsche Bank's SYNH Position: Q3 2023 in Review

Deutsche Bank sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,624,447 shares — an estimated $68.5M sold.

Deutsche Bank first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $68.5M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Deutsche Bank reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Deutsche Bank sold 1,624,447 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $68.5M.
Deutsche Bank first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
Deutsche Bank's Syneos Health, Inc. Class A Common Stock position peaked at $68.5M in Q2 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.